Works by Rawwas, Jawhar

Results: 10
    1

    RAS pathway targeted therapy in patients with DICER1-associated sarcomas.

    Published in:
    NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-01026-0
    By:
    • Zhang, Lindy;
    • Mallinger, Paige H. R.;
    • Zhou, Serena;
    • Makri, Stavriani C.;
    • Gross, John M.;
    • Lucas, Calixto-Hope G.;
    • Zou, Ying S.;
    • Mize, William;
    • Olson, Damon R.;
    • Munnikhuysen, Senna R.;
    • Rawwas, Jawhar;
    • Messinger, Yoav;
    • Chen, Kenneth S.;
    • Schultz, Kris Ann P.;
    • Pratilas, Christine A.
    Publication type:
    Article
    2
    3

    Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.

    Published in:
    2016
    By:
    • Pinto, Navin;
    • Mayfield, Jodi R.;
    • Raca, Gordana;
    • Applebaum, Mark A.;
    • Chlenski, Alexandre;
    • Sukhanova, Madina;
    • Bagatell, Rochelle;
    • Irwin, Meredith S.;
    • Little, Anthony;
    • Rawwas, Jawhar;
    • Gosiengfiao, Yasmin;
    • Delattre, Olivier;
    • Janoueix‐Lerosey, Isabelle;
    • Lapouble, Eve;
    • Schleiermacher, Gudrun;
    • Cohn, Susan L.
    Publication type:
    journal article
    4

    Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.

    Published in:
    Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01297-5
    By:
    • Sholler, Giselle L. Saulnier;
    • Bergendahl, Genevieve;
    • Lewis, Elizabeth C.;
    • Kraveka, Jacqueline;
    • Ferguson, William;
    • Nagulapally, Abhinav B.;
    • Dykema, Karl;
    • Brown, Valerie I.;
    • Isakoff, Michael S.;
    • Junewick, Joseph;
    • Mitchell, Deanna;
    • Rawwas, Jawhar;
    • Roberts, William;
    • Eslin, Don;
    • Oesterheld, Javier;
    • Wada, Randal K.;
    • Pastakia, Devang;
    • Harrod, Virginia;
    • Ginn, Kevin;
    • Saab, Raya
    Publication type:
    Article
    5

    Maintenance DFMO Increases Survival in High Risk Neuroblastoma.

    Published in:
    Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32659-w
    By:
    • Sholler, Giselle L. Saulnier;
    • Ferguson, William;
    • Bergendahl, Genevieve;
    • Bond, Jeffrey P.;
    • Neville, Kathleen;
    • Eslin, Don;
    • Brown, Valerie;
    • Roberts, William;
    • Wada, Randal K.;
    • Oesterheld, Javier;
    • Mitchell, Deanna;
    • Foley, Jessica;
    • Parikh, Nehal S.;
    • Eshun, Francis;
    • Zage, Peter;
    • Rawwas, Jawhar;
    • Sencer, Susan;
    • Pankiewicz, Debra;
    • Quinn, Monique;
    • Rich, Maria
    Publication type:
    Article
    6

    A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 5, p. 1026, doi. 10.1002/ijc.34569
    By:
    • Eslin, Don;
    • Zage, Peter E.;
    • Bergendahl, Genevieve;
    • Lewis, Elizabeth;
    • Roberts, William;
    • Kraveka, Jacqueline;
    • Mitchell, Deanna;
    • Isakoff, Michael S.;
    • Rawwas, Jawhar;
    • Wada, Randal K.;
    • Fluchel, Mark;
    • Brown, Valerie I.;
    • Ginn, Kevin;
    • Higgins, Timothy;
    • BeeravallyNagulapally, Abhinav;
    • Dykema, Karl;
    • Hanna, Gina;
    • Ferguson, William;
    • Saulnier Sholler, Giselle L.
    Publication type:
    Article
    7

    A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma.

    Published in:
    International Journal of Cancer, 2020, v. 147, n. 11, p. 3152, doi. 10.1002/ijc.33044
    By:
    • Lewis, Elizabeth C.;
    • Kraveka, Jacqueline M.;
    • Ferguson, William;
    • Eslin, Don;
    • Brown, Valerie I.;
    • Bergendahl, Genevieve;
    • Roberts, William;
    • Wada, Randal K.;
    • Oesterheld, Javier;
    • Mitchell, Deanna;
    • Foley, Jessica;
    • Zage, Peter;
    • Rawwas, Jawhar;
    • Rich, Maria;
    • Lorenzi, Elizabeth;
    • Broglio, Kristine;
    • Berry, Donald;
    • Saulnier Sholler, Giselle L.
    Publication type:
    Article
    8
    9

    A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma.

    Published in:
    Cancer Reports, 2022, v. 5, n. 11, p. 1, doi. 10.1002/cnr2.1616
    By:
    • Kraveka, Jacqueline M.;
    • Lewis, Elizabeth C.;
    • Bergendahl, Genevieve;
    • Ferguson, William;
    • Oesterheld, Javier;
    • Kim, Elizabeth;
    • Nagulapally, Abhinav B.;
    • Dykema, Karl J.;
    • Brown, Valerie I.;
    • Roberts, William D.;
    • Mitchell, Deanna;
    • Eslin, Don;
    • Hanson, Derek;
    • Isakoff, Michael S.;
    • Wada, Randal K.;
    • Harrod, Virginia L.;
    • Rawwas, Jawhar;
    • Hanna, Gina;
    • Hendricks, William P. D.;
    • Byron, Sara A.
    Publication type:
    Article
    10

    PET Hydroxyephedrine Imaging of Neuroblastoma.

    Published in:
    Journal of Nuclear Medicine, 1996, v. 37, n. 1, p. 16
    By:
    • Shulkin, Barry L.;
    • Wieland, Donald M.;
    • Baro, Marie E.;
    • Ungar, David R.;
    • Mitchell, Deanna S.;
    • Dole, Mukund G.;
    • Rawwas, Jawhar B.;
    • Castle, Valerie P.;
    • Sisson, James C.;
    • Hutchinson, Raymond J.
    Publication type:
    Article